Tuesday, August 16, 2022 8:57:50 PM
In such case, this placebo called Lenzwhatever will be useless re: patients who have already had GM-CSFsignalling and cytokine storm initiation, and subsequent inactivation of CM-CSF signalling, if any, is useless, as the data shows that it is.
Mebbe crufty ole grifter CURRANT can file a trademark registration application for PLACEBEX for this Lenzogunk crapola.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM